MTRX1011A, a humanized anti-CD4 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a Phase I randomized, double-blind, placebo-controlled study incorporating pharmacodynamic biomarker assessments
Titel:
MTRX1011A, a humanized anti-CD4 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a Phase I randomized, double-blind, placebo-controlled study incorporating pharmacodynamic biomarker assessments
Auteur:
Scheerens, Heleen Su, Zheng Irving, Bryan Townsend, Michael J Zheng, Yanan Stefanich, Eric Chindalore, Vishala Bingham, Clifton O Davis, John C